Tradestie Institutional Equity Comparison Engine

SNOA vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNOA Overall Edge

SNOA Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) driven by superior Valuation, Growth & Margin while BMRA counters with relative strength in Momentum & Technical. Fundamentally, SNOA trades at 46.1x Forward P/E with -3.3% operating margin (+28.0% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, SNOA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SNOA
SNOA 46.1x vs BMRA N/M Fwd P/E
Growth & Margin Winner SNOA
Op Margin -3.3% vs -125.2% ยท YoY +28.0% vs -8.3%
Momentum & Technical Winner BMRA
1Y -76.2% vs -46.9% ยท 52W Pos 1% vs 4%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SNOA NASDAQ
Sonoma Pharmaceuticals, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.84
-22.68% 1D
Market Cap $5.6M
1M Return -24.75%
1Y Return -76.19%
Forward P/E 46.1x
Unified AI Score
51.6 / 100 HOLD
Tech 49.0 Fund 52.0 Flow 50.0 Mom 54.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNOA -76.19% BMRA -46.86% Spread: +29.33 pp (BMRA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SNOA Revenue BMRA Revenue SNOA Op. Margin BMRA Op. Margin Margin Edge
FY2019 $20M $10M -59.3% -46.4% BMRA
FY2020 $20M $10M -41.2% -41.0% BMRA
FY2021 $20M $10M -18.5% -104.2% SNOA
FY2022 $10M $20M -46.6% -24.0% BMRA
FY2023 $10M $10M -34.4% -135.3% SNOA
FY2024 $10M $10M -36.9% -117.6% SNOA
FY2025 $10M $10M -26.0% -96.7% SNOA
FY2026 $20M $0M -12.6% -119.5% SNOA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNOA (7) vs BMRA (2)
Institutional Metric SNOA BMRA Criterion Row Winner
Market Capitalization Scale $5.6M $6.0M Larger Scale Tie
Trailing P/E Ratio Valuation 46.1x N/M Lower Multiple SNOA
Forward P/E Ratio Valuation 46.1x N/M Lower Multiple SNOA
Revenue Growth (YoY) Growth +28.0% -8.3% Higher Growth SNOA
Operating Margin (TTM) Profitability -3.3% -125.2% Higher Margin SNOA
Net Profit Margin Profitability -7.6% -115.5% Higher Margin SNOA
Return on Equity (ROE) Capital Efficiency -34.5% -113.8% Higher ROE SNOA
52-Week Range Position Momentum 1% ($1โ€“$4) 4% ($1โ€“$3) Stronger Trend BMRA
Beta / 30D Volatility Risk Regime 1.39ฮฒ ยท 78% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite SNOA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNOA vs BMRA Buy Guide
SNOA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNOA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNOA nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.